[English] 日本語
Yorodumi
- PDB-5wob: Crystal Structure Analysis of Fab1-Bound Human Insulin Degrading ... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 5wob
TitleCrystal Structure Analysis of Fab1-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Insulin
Components
  • IDE-bound Fab heavy chain
  • IDE-bound Fab light chain
  • Insulin
  • Insulin-degrading enzyme
KeywordsHYDROLASE / complex
Function / homology
Function and homology information


insulysin / beta-endorphin binding / ubiquitin recycling / insulin catabolic process / insulin metabolic process / amyloid-beta clearance by cellular catabolic process / hormone catabolic process / bradykinin catabolic process / cytosolic proteasome complex / positive regulation of protein binding ...insulysin / beta-endorphin binding / ubiquitin recycling / insulin catabolic process / insulin metabolic process / amyloid-beta clearance by cellular catabolic process / hormone catabolic process / bradykinin catabolic process / cytosolic proteasome complex / positive regulation of protein binding / insulin binding / : / negative regulation of glycogen catabolic process / regulation of aerobic respiration / negative regulation of fatty acid metabolic process / Signaling by Insulin receptor / IRS activation / Insulin processing / regulation of protein secretion / negative regulation of feeding behavior / positive regulation of peptide hormone secretion / peptide catabolic process / negative regulation of acute inflammatory response / Regulation of gene expression in beta cells / positive regulation of respiratory burst / amyloid-beta metabolic process / peroxisomal matrix / alpha-beta T cell activation / amyloid-beta clearance / Synthesis, secretion, and deacylation of Ghrelin / negative regulation of proteolysis / negative regulation of gluconeogenesis / negative regulation of protein secretion / positive regulation of dendritic spine maintenance / fatty acid homeostasis / positive regulation of brown fat cell differentiation / positive regulation of glycogen biosynthetic process / positive regulation of insulin receptor signaling pathway / Signal attenuation / FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes / positive regulation of lipid biosynthetic process / negative regulation of respiratory burst involved in inflammatory response / negative regulation of lipid catabolic process / negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway / nitric oxide-cGMP-mediated signaling / regulation of protein localization to plasma membrane / transport vesicle / Insulin receptor recycling / COPI-mediated anterograde transport / positive regulation of nitric-oxide synthase activity / negative regulation of reactive oxygen species biosynthetic process / insulin-like growth factor receptor binding / NPAS4 regulates expression of target genes / protein catabolic process / peptide binding / positive regulation of D-glucose import across plasma membrane / positive regulation of mitotic nuclear division / neuron projection maintenance / endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of glycolytic process / Insulin receptor signalling cascade / : / endosome lumen / positive regulation of protein secretion / acute-phase response / positive regulation of cytokine production / wound healing / insulin receptor binding / positive regulation of long-term synaptic potentiation / positive regulation of neuron projection development / glucose metabolic process / positive regulation of cell differentiation / negative regulation of protein catabolic process / Peroxisomal protein import / Regulation of insulin secretion / regulation of synaptic plasticity / antigen processing and presentation of endogenous peptide antigen via MHC class I / hormone activity / metalloendopeptidase activity / positive regulation of protein localization to nucleus / vasodilation / Golgi lumen / cognition / insulin receptor signaling pathway / positive regulation of protein catabolic process / glucose homeostasis / regulation of protein localization / cell-cell signaling / peroxisome / positive regulation of cell growth / amyloid-beta binding / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / virus receptor activity / protease binding / secretory granule lumen / endopeptidase activity / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / basolateral plasma membrane / positive regulation of MAPK cascade / positive regulation of canonical NF-kappaB signal transduction
Similarity search - Function
Peptidase M16, middle/third domain / Middle or third domain of peptidase_M16 / : / PQQ synthase PqqF-like, C-terminal lobe domain 4 / : / Cytochrome Bc1 Complex; Chain A, domain 1 / Metalloenzyme, LuxS/M16 peptidase-like / Peptidase M16, zinc-binding site / Insulinase family, zinc-binding region signature. / Peptidase M16, C-terminal ...Peptidase M16, middle/third domain / Middle or third domain of peptidase_M16 / : / PQQ synthase PqqF-like, C-terminal lobe domain 4 / : / Cytochrome Bc1 Complex; Chain A, domain 1 / Metalloenzyme, LuxS/M16 peptidase-like / Peptidase M16, zinc-binding site / Insulinase family, zinc-binding region signature. / Peptidase M16, C-terminal / Peptidase M16 inactive domain / Peptidase M16, N-terminal / Insulinase (Peptidase family M16) / Metalloenzyme, LuxS/M16 peptidase-like / Insulin / Insulin family / Insulin-like / Insulin/IGF/Relaxin family / Insulin / insulin-like growth factor / relaxin family. / Insulin, conserved site / Insulin family signature. / Insulin-like superfamily / Immunoglobulins / Immunoglobulin-like / Sandwich / 2-Layer Sandwich / Mainly Beta / Alpha Beta
Similarity search - Domain/homology
Insulin / Insulin-degrading enzyme
Similarity search - Component
Biological speciesHomo sapiens (human)
Mus musculoides (Temminck's mouse)
MethodX-RAY DIFFRACTION / SYNCHROTRON / Resolution: 3.95 Å
AuthorsMcCord, L.A. / Liang, W.G. / Farcasanu, M. / Wang, A.G. / Koide, S. / Tang, W.J.
Funding support United States, 1items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)GM121964 United States
CitationJournal: Elife / Year: 2018
Title: Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
Authors: Zhening Zhang / Wenguang G Liang / Lucas J Bailey / Yong Zi Tan / Hui Wei / Andrew Wang / Mara Farcasanu / Virgil A Woods / Lauren A McCord / David Lee / Weifeng Shang / Rebecca Deprez- ...Authors: Zhening Zhang / Wenguang G Liang / Lucas J Bailey / Yong Zi Tan / Hui Wei / Andrew Wang / Mara Farcasanu / Virgil A Woods / Lauren A McCord / David Lee / Weifeng Shang / Rebecca Deprez-Poulain / Benoit Deprez / David R Liu / Akiko Koide / Shohei Koide / Anthony A Kossiakoff / Sheng Li / Bridget Carragher / Clinton S Potter / Wei-Jen Tang /
Abstract: Insulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type two diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes ...Insulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type two diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes peptides that tend to form amyloid fibrils remained unsolved. We used cryoEM to understand both the apo- and insulin-bound dimeric IDE states, revealing that IDE displays a large opening between the homologous ~55 kDa N- and C-terminal halves to allow selective substrate capture based on size and charge complementarity. We also used cryoEM, X-ray crystallography, SAXS, and HDX-MS to elucidate the molecular basis of how amyloidogenic peptides stabilize the disordered IDE catalytic cleft, thereby inducing selective degradation by substrate-assisted catalysis. Furthermore, our insulin-bound IDE structures explain how IDE processively degrades insulin by stochastically cutting either chain without breaking disulfide bonds. Together, our studies provide a mechanism for how IDE selectively degrades amyloidogenic peptides and offers structural insights for developing IDE-based therapies.
History
DepositionAug 1, 2017Deposition site: RCSB / Processing site: RCSB
SupersessionApr 18, 2018ID: 4Q5Z
Revision 1.0Apr 18, 2018Provider: repository / Type: Initial release
Revision 1.1Oct 30, 2019Group: Data collection / Database references / Category: citation / citation_author
Item: _citation.country / _citation.journal_abbrev ..._citation.country / _citation.journal_abbrev / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.journal_volume / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Mar 23, 2022Group: Author supporting evidence / Database references / Category: database_2 / pdbx_audit_support
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_audit_support.funding_organization / _pdbx_audit_support.grant_number
Revision 1.3Oct 4, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model
Revision 1.4Oct 23, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Insulin-degrading enzyme
B: Insulin-degrading enzyme
C: Insulin-degrading enzyme
D: Insulin-degrading enzyme
E: Insulin-degrading enzyme
F: Insulin-degrading enzyme
G: Insulin-degrading enzyme
H: Insulin-degrading enzyme
a: Insulin
b: Insulin
c: Insulin
d: Insulin
e: Insulin
f: Insulin
g: Insulin
h: Insulin
I: IDE-bound Fab heavy chain
K: IDE-bound Fab heavy chain
M: IDE-bound Fab heavy chain
O: IDE-bound Fab heavy chain
Q: IDE-bound Fab heavy chain
S: IDE-bound Fab heavy chain
U: IDE-bound Fab heavy chain
W: IDE-bound Fab heavy chain
J: IDE-bound Fab light chain
L: IDE-bound Fab light chain
N: IDE-bound Fab light chain
P: IDE-bound Fab light chain
R: IDE-bound Fab light chain
T: IDE-bound Fab light chain
V: IDE-bound Fab light chain
X: IDE-bound Fab light chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)1,368,63540
Polymers1,368,11232
Non-polymers5238
Water00
1
A: Insulin-degrading enzyme
B: Insulin-degrading enzyme
a: Insulin
b: Insulin
I: IDE-bound Fab heavy chain
K: IDE-bound Fab heavy chain
J: IDE-bound Fab light chain
L: IDE-bound Fab light chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)342,15910
Polymers342,0288
Non-polymers1312
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
C: Insulin-degrading enzyme
D: Insulin-degrading enzyme
c: Insulin
d: Insulin
M: IDE-bound Fab heavy chain
O: IDE-bound Fab heavy chain
N: IDE-bound Fab light chain
P: IDE-bound Fab light chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)342,15910
Polymers342,0288
Non-polymers1312
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
3
E: Insulin-degrading enzyme
F: Insulin-degrading enzyme
e: Insulin
f: Insulin
Q: IDE-bound Fab heavy chain
S: IDE-bound Fab heavy chain
R: IDE-bound Fab light chain
T: IDE-bound Fab light chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)342,15910
Polymers342,0288
Non-polymers1312
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
4
G: Insulin-degrading enzyme
H: Insulin-degrading enzyme
g: Insulin
h: Insulin
U: IDE-bound Fab heavy chain
W: IDE-bound Fab heavy chain
V: IDE-bound Fab light chain
X: IDE-bound Fab light chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)342,15910
Polymers342,0288
Non-polymers1312
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)121.589, 138.190, 376.509
Angle α, β, γ (deg.)90.00, 99.36, 90.00
Int Tables number4
Space group name H-MP1211

-
Components

#1: Protein
Insulin-degrading enzyme / Abeta-degrading protease / Insulin protease / Insulinase / Insulysin


Mass: 114560.578 Da / Num. of mol.: 8 / Fragment: UNP residues 42-1019
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: IDE / Production host: Escherichia coli (E. coli) / References: UniProt: P14735, insulysin
#2: Protein/peptide
Insulin


Mass: 2269.595 Da / Num. of mol.: 8
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: INS / Production host: Saccharomyces cerevisiae (brewer's yeast) / References: UniProt: P01308
#3: Antibody
IDE-bound Fab heavy chain


Mass: 28201.670 Da / Num. of mol.: 8
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Mus musculoides (Temminck's mouse) / Production host: Escherichia coli (E. coli)
#4: Antibody
IDE-bound Fab light chain


Mass: 25982.098 Da / Num. of mol.: 8
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Mus musculoides (Temminck's mouse) / Production host: Escherichia coli (E. coli)
#5: Chemical
ChemComp-ZN / ZINC ION


Mass: 65.409 Da / Num. of mol.: 8 / Source method: obtained synthetically / Formula: Zn / Feature type: SUBJECT OF INVESTIGATION
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.28 Å3/Da / Density % sol: 46.08 %
Crystal growTemperature: 291.15 K / Method: vapor diffusion, hanging drop / pH: 6.5
Details: 0.1M Sodium cacodylate, pH6.5; 0.2M MgCl2; 10% PEG3000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 19-ID / Wavelength: 0.9792 Å
DetectorType: ADSC QUANTUM 315r / Detector: CCD / Date: Jul 11, 2013
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9792 Å / Relative weight: 1
ReflectionResolution: 3.95→50 Å / Num. obs: 108370 / % possible obs: 99.5 % / Observed criterion σ(F): 2.1 / Observed criterion σ(I): 2.1 / Redundancy: 3.3 % / Rmerge(I) obs: 0.2 / Rpim(I) all: 0.13 / Rsym value: 0.12 / Χ2: 1.277 / Net I/σ(I): 7
Reflection shellResolution: 3.95→4.02 Å / Redundancy: 3.3 % / Rmerge(I) obs: 0.672 / Mean I/σ(I) obs: 2.1 / Num. unique obs: 5406 / CC1/2: 0.583 / Rpim(I) all: 0.424 / Rsym value: 0.621 / Χ2: 1.02 / % possible all: 99.8

-
Processing

Software
NameVersionClassification
PHENIX1.10.1_2155refinement
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing
RefinementStarting model: 4IOF

4iof


Resolution: 3.95→49.543 Å / Cross valid method: FREE R-VALUE / σ(F): 1.34 / Phase error: 26.49
RfactorNum. reflection% reflection
Rfree0.291 1994 1.85 %
Rwork0.2431 --
obs0.2439 107673 99.45 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å
Refinement stepCycle: LAST / Resolution: 3.95→49.543 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms86898 0 8 0 86906
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.00288973
X-RAY DIFFRACTIONf_angle_d0.453120368
X-RAY DIFFRACTIONf_dihedral_angle_d15.42153581
X-RAY DIFFRACTIONf_chiral_restr0.03913128
X-RAY DIFFRACTIONf_plane_restr0.00415391
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.9505-4.04930.30941450.28367569X-RAY DIFFRACTION98
4.0493-4.15870.31041420.27427464X-RAY DIFFRACTION98
4.1587-4.2810.33811410.26437555X-RAY DIFFRACTION98
4.281-4.41910.34871380.25757487X-RAY DIFFRACTION98
4.4191-4.57690.28871420.24037578X-RAY DIFFRACTION98
4.5769-4.760.26081410.22797537X-RAY DIFFRACTION98
4.76-4.97650.25531420.21227536X-RAY DIFFRACTION98
4.9765-5.23860.25911390.22257537X-RAY DIFFRACTION98
5.2386-5.56640.27911420.24067589X-RAY DIFFRACTION98
5.5664-5.99550.34431390.25627546X-RAY DIFFRACTION98
5.9955-6.59760.31741410.28237570X-RAY DIFFRACTION98
6.5976-7.54940.29091420.25147541X-RAY DIFFRACTION97
7.5494-9.50040.2521400.20457462X-RAY DIFFRACTION96
9.5004-49.54670.29751430.24127694X-RAY DIFFRACTION97

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more